Product NDC: | 52584-036 |
Proprietary Name: | NALOXONE HYDROCHLORIDE |
Non Proprietary Name: | naloxone hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; naloxone hydrochloride |
Administration Route(s): | PARENTERAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-036 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072076 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120829 |
Package NDC: | 52584-036-05 |
Package Description: | 1 BAG in 1 BOX (52584-036-05) > 1 SYRINGE in 1 BAG > 2 mL in 1 SYRINGE |
NDC Code | 52584-036-05 |
Proprietary Name | NALOXONE HYDROCHLORIDE |
Package Description | 1 BAG in 1 BOX (52584-036-05) > 1 SYRINGE in 1 BAG > 2 mL in 1 SYRINGE |
Product NDC | 52584-036 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | naloxone hydrochloride |
Dosage Form Name | INJECTION |
Route Name | PARENTERAL |
Start Marketing Date | 20120829 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | NALOXONE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |